Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Cognitive Function Study of EVP-6124 in Patients With Alzheimer's Disease
This study has been completed.
Study NCT00766363   Information provided by EnVivo Pharmaceuticals, Inc.
First Received: October 1, 2008   Last Updated: March 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer's Disease
Central Nervous System Diseases
Additional conditions recognized in this trial
Alzheimer Disease
Nervous System Diseases
More general conditions related to this trial
Brain Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
EVP-6124
placebo
Additional drug interventions recognized in this trial
Nicotinic Agonists
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
EnVivo Pharmaceuticals, Inc.
INC Research Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services